SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SANJIVANI PARANTERAL

BSE: 531569 29 Sep 2025
Healthcare
₹ 235.5
Sanjivani Paranteral Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SANJIVANI PARANTERAL - Share Price & Details

Market Cap
₹285.0
High /Low
397.0 / 203.0
Stock P/E
35.1
Book Value
₹32.0
Dividend Yield
0.22
ROCE
28.5
ROE
₹24.6
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹24.6
Debt
8.14
CMP / FCF
NA
Debt to equity
₹0.21
NP Ann
8.09
High price all time
397.0
Piotroski score
₹3.0
Graham Number
70.2
No. Eq. Shares
1.23
Net CF
₹0.94
Net profit
8.12
Price to book value
7.25
Interest Coverage
₹14.1
Low price all time
3.17
Industry PE
33.0
Reserves
₹26.1
Free Cash Flow
₹-18.0

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
SANJIVANI PARANTERAL LTD.NANANANA285.035.1
NATURAL CAPSULES LTD.455.62-55.8452.03-5.428136.2
Nureca Limited369.165.52343.240.55278

Peer Comparison Chart


About SANJIVANI PARANTERAL

Sanjivani Paranteral Ltd., with Security Code 531569, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

SPL Infusion commences commercial production of new IV fluid Infusion plant

(10 Sep 2025)
Sanjivani Paranteral Limited's subsidiary, SPL Infusion Pvt. Ltd., has commenced commercial production at its newly established IV Fluid...
Read more →

Sanjivani Paranteral Hits New Low Amid Broader Market Decline and Mixed Financial Indicators

(22 Aug 2025)
Sanjivani Paranteral, a microcap in the Pharmaceuticals & Biotechnology sector, reached a new 52-week low today, reversing a two-day gain trend.
Read more →

Sanjivani Paranteral Reports Mixed Financial Results Amid Growth and Profitability Challenges in August 2025

(13 Aug 2025)
Sanjivani Paranteral has reported its financial results for the quarter ending June 2025, revealing a mixed performance.
Read more →

Sanjivani Paranteral consolidated net profit rises 1.17% in the June 2025 quarter

(13 Aug 2025)
Net profit of Sanjivani Paranteral rose 1.17% to Rs 1.73 crore in the quarter ended June 2025 as against Rs 1.71 crore during the previous...
Read more →

Landmark Property Development Company Limited (LPDC) to Launch New Product Line - Discover market opportunities with real-time data

(03 Aug 2025)
【Growth Stocks】✌️ Our in-depth financial models assess earnings quality, cash flow strength, and market sentiment to find stocks with the...
Read more →

Is LCCCU stock overvalued or undervalued - Capitalize on fast-moving stock trends

(28 Jul 2025)
【Market Focus】✌️ Get ahead of the market with live updates and strategic insights.
Read more →